<DOC>
	<DOCNO>NCT01876589</DOCNO>
	<brief_summary>The purpose study examine improvement myocardial blood flow induce regained vasomotor function stented coronary segment resorption BVS time .</brief_summary>
	<brief_title>Impact Vascular Reparative Therapy Vasomotor Function Myocardial Perfusion : Randomized H215O PET/CT Study</brief_title>
	<detailed_description>Objective The objective propose study determine impact VRT , comparison conventional drug-eluting stenting , endothelium dependent vasodilation maximal hyperemic myocardial perfusion use H215O PET . Study design The study design single center single-blind randomized clinical trial conduct VU University Medical Center Amsterdam . Summary study design It hypothesize VRT result augment endothelium dependent coronary vasodilation maximal myocardial perfusion compare conventional stenting coronary lesion . Within one year sixty patient ( age 18-65 ) document single vessel CAD ( type A B1 lesion ) accept PCI base clinical ground accord current international guideline , ask participate trial . Patients randomized implantation drug-eluted stent ( Xience Prime ) BRS ( Absorb ) . The patient blind nature implant device . H2 15O PET perform one month ( reference scan ) , one year , three year PCI procedure ( resolution BRS generally complete within three year period ) . The PET protocol consist three MBF measurement : resting MBF , endothelial dependent vasodilation provoke coldpressor-testing ( CPT ) , ( endothelial dependent independent ) maximal vasodilation infusion adenosine intravenously . After three year control invasive coronary angiogram document potential obstructive coronary lesion may affect MBF measurement . Primary study parameters/outcome study MBF measurement : resting MBF , endothelial dependent vasodilation provoke cold-pressor-testing ( CPT ) , ( endothelial dependent independent ) maximal vasodilation infusion adenosine intravenously Secondary study parameters/outcome study Obstructive coronary lesion control invasive coronary angiogram may affect MBF measurement .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients document obstructive CAD invasive coronary angiography result myocardial ischemia ( either document invasive ( i.e . fractional flow reserve , FFR ) noninvasive image technique ( e.g . exercise ECG , myocardial perfusion imaging , inducibility wall motion abnormality dobutamine stress ) . Presence single , denovo lesion native coronary artery ( type A B1 ) , reference vessel diameter least 3.0 mm diameter stenosis 50 % le 100 % , thrombolysis myocardial infarction ( TIMI ) flow grade least 2 . Coronary lesion must amendable successful treatment one follow BRS device dimension : length 18 28 mm , diameter 3.0 3.5 mm . age 65 refusal inability provide write informed consent single CAD abnormal echocardiographic finding ( i.e . wall motion abnormality , ventricular hypertrophy , valvular disease etc . ) complex coronary lesion characteristic ( e.g . lesion locate leave main coronary artery , lesion involve side branch 2 mm diameter , presence thrombus another clinically significant stenosis target vessel ) poor kidney function define eGFR &lt; 30 ml/min astma chronic obstructive pulmonary disease sinus rhythm pregnancy bail stenting placement study device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Coronary Artery Disease ( CAD )</keyword>
	<keyword>Invasive coronary angiography ( ICA )</keyword>
	<keyword>Positron Emission Tomography ( PET )</keyword>
</DOC>